Search for:
Search for:
Healthcare Professionals
Publications
News
EspaƱol
Contact
Magazine
Radio
Get Educated
What is MS?
A chronic neurological disorder that affects the central nervous system, comprised of the brain...
More Details
Educational Materials
Common Questions
Lending Library
Symptoms
Treatment Options
Additional Resources
Research
MS Awareness Month
Donate
Get Help
Health & Wellness Program
Get educational materials and referrals, as well as the opportunity to participate in various...
Learn More
Grants & Programs
Awareness Campaigns
Support Groups
Events
Lending Library
Additional Resources
Get Involved
MS Awareness Month
An annual, nationwide campaign with goals to promote an understanding of MS, and to assist those...
Learn More
Advocacy
Buy from Partners
Volunteer
Businesses
MS Research Trials
Outreach
Awareness Campaigns
Host an Event
Events
Test Flyout
lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem...
Learn More
Events Calendar
Health & Wellness
Fundraisers
Support
Web & Teleconferences
MS Education
Host an Event
About Us
Programs & Grants
More Details
Overview
Press Room
Leadership
Financial Statements
Our Mission
Careers at MS Focus
Affiliations
News & Features
MS Focus At Sea
MS Focus At Sea offers educational programs, opportunities to meet old and new friends, and adventures for every...
/Events/MSF-Events/MSFocus-Cruise-For-A-Cause
Brighter Tomorrow Grant
The Brighter Tomorrow Grant allows MS Focus to makes dreams come true for people with MS across...
/Get-Help/MSF-Programs-Grants/Brighter-Tomorrow-Grant
Shop
Privacy
Terms of Use
Site Map
Study suggests potential genetic markers of MS-related vision loss
November 01, 2019
In a bid to determine factors linked to the most debilitating forms of multiple sclerosis, researchers say they have identified three so-called "complement system" genes that appear to play a role in MS-caused vision loss. If further studies confirm the findings, the study’s authors said they could serve as markers for monitoring and predicting progression and severity of MS. According to the researchers, this approach represents the beginning of precision medicine for MS and may ultimately allow designer therapies, as is being done for specific cancers.
For their study, researchers at Johns Hopkins Medicine used optical coherence tomography – an imaging technique that allowed the researchers to look at the back of each patient's eyes and assess damage to the nerve cells in the retina – in 374 patients with all types of MS. The patients were an average of 43 years old and mostly women.
The investigators recruited these patients and performed imaging every few years from 2010 to 2017, yielding an average of 4.6 scans per participant over the course of the study. The scans were used to measure thinning of the layer of the nerve cells – known as ganglion cells – in the retina over time. The average rate of deterioration was a loss of 0.32 micrometers of tissue per year in each patient.
Then, using blood samples from the patients to collect their DNA, the researchers hunted for genetic mutations in those people with the fastest deterioration rates and identified 23 such DNA variations that mapped to the complement gene C3.
Next, to search for genes further linked to vision loss, they performed an analysis of an existing clinical trial group of another 835 people with MS, of whom 74 percent were women, and whose average age was 40. Each participant underwent periodic vision testing about every year to distinguish their ability to detect contrast – finer and finer shades that distinguish light versus dark.
Using DNA from the blood samples of these 835 participants, the researchers identified specific genetic changes in two complement genes, C1QA and CR1, linked to those people with the most rapidly declining ability to distinguish letters with less contrast. Patients with genetic changes in the C1QA gene were 71 percent more likely to develop difficulty detecting visual contrast, whereas those with genetic changes in the CR1 gene were at 40 percent increased risk for developing a reduced ability to detect contrast.
These complement genes found to be linked with severity of MS vision loss hold the genetic instructions for making complement proteins.
The findings were reported in the journal
Brain
.
MS Focus Lending Library
Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more